Evolus, Inc. (EOLS) vs Alpha Teknova, Inc. (TKNO)
- Evolus, Inc. EOLS 7.10 −6.21%
- Alpha Teknova, Inc. TKNO 7.08 −6.84%
Evolus, Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. is the larger, with a market value of $500.0M against $408.0M — 1.2× the size. Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against 12.3%. Evolus, Inc. has the higher net margin (−10.9% vs −38.4%) and the higher return on invested capital (−14.5% vs −16.9%). Across the 17 metrics below, Evolus, Inc. leads on 13 and Alpha Teknova, Inc. on 4.
Valuation
Profitability
| Metric | EOLS | TKNO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.74% | 34.60% | 53.94% |
| Operating margin | (5.90%) | (36.19%) | 0.00% |
| Net margin | (10.85%) | (38.37%) | 0.00% |
| Free cash flow margin | (6.92%) | (16.83%) | 0.00% |
| Return on equity | 138.57% | (24.19%) | (0.40%) |
| Return on assets | (14.40%) | (16.25%) | (3.32%) |
| Return on invested capital | (14.47%) | (16.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack